A PHP Error was encountered

Severity: Notice

Message: Only variable references should be returned by reference

Filename: core/Common.php

Line Number: 257

A PHP Error was encountered

Severity: Warning

Message: Cannot modify header information - headers already sent by (output started at /home/biomagaz/cwcms_core/system/core/Exceptions.php:185)

Filename: core/Security.php

Line Number: 188

A PHP Error was encountered

Severity: Warning

Message: Cannot modify header information - headers already sent by (output started at /home/biomagaz/cwcms_core/system/core/Exceptions.php:185)

Filename: libraries/Session.php

Line Number: 672

BIO Magazine - Biotechnology and Its Future in Algeria Δεκέμβριος 2015
Δεκέμβριος 2015 No38

BIO Patent

Biotechnology and Its Future in  Algeria
Biotechnology and Its Future in Algeria

Overview

  • Introduction of Amgen
  • Value of Innovation
  • Importance of Partnerships
  • Keys to Success
  • Conclusion

Amgen: A Biotechnology Pioneer

Founded in 1980, Amgen was one of the first biotechnology companies to successfully discover, develop, and make protein-based medicines

Today, we’re leading the industry in its next wave of innovation by:

  • Developing therapies in multiple modalities
  • Driving cutting-edge research and development
  • Continuing to advance the science of biotechnological manufacturing

Biotechnology Is the Future of Medicine

  • Industry only ~ 35 years old, yet already more than 500 million people have been helped by biotechnology medicines
  • > 300 biotechnology therapeutics available; many more awaiting regulatory approval
  • Thousands of new medicines in clinical trials; hundreds in late stage
  • >50% of all therapies in development today are biotechnology medicines
Read more...

http://www.us-algeria.org/presentations/PRESENTATION 2011 health allam second session.pdf

<< Επιστροφή στην λίστα

© BIO | info@biomagazine.gr

Powered by CreativeWorks